Crossmark

Influence of genetic variants of imatinib on pharmacokinetics and recurrence-free survival in postoperative patients with gastrointestinal stromal tumor

Crossref DOI link: https://doi.org/10.1007/s00228-025-03922-7

Published Online: 2025-10-06

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sun, Luning

Xu, Mingqing

Zhang, Qiang

Liu, Yi

Huang, Qiongye

Xu, Jianghao

Li, Fengyuan

Xu, Hao

Wang, Yongqing
Funding

Funding for this research was provided by:

the grants from National Natural Sciences Foundation of China (82274022)

the third session of the support programs for topnotch talents, Jiangsu Provincial People’s Hospital, China (YNRCQN025)

Jiangsu Pharmaceutical Association-Aosaikang Pharmaceutical Co.Ltd Hospital Pharmacy Research Key Project (A202204)
License Information

Text and Data Mining valid from 2025-10-06

Version of Record valid from 2025-10-06
More Information

Article History

Received: 9 April 2025

Accepted: 1 September 2025

First Online: 6 October 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below